Summary
Fluphenazine and chlordiazepoxide were evaluated for therapeutic effectiveness in a double-blind study carried out with anxious neurotic patients attending either a hospital clinic or a general practitioner's office.
All patients had significantly lower psychopathology scores after treatment than before, the general practice sample improving significantly more than the hospital clinic sample. While there was no significant difference in the degree of improvement produced by each drug in the general practice sample, in the hospital clinic sample, chlordiazepoxide was significantly more effective than fluphenazine, but only when using the somatic symptom cluster of the Physician Questionnaire as improvement criterion.
Differences in population characteristics, primarily in social class and its related variables, but also in treatment set were suggested as important non-specific factors, which, by interactions with specific drug effects, influenced significantly the results observed in the present study. This study thus confirms the 2 hypotheses stated earlier in the introduction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Batterman, R. C., G. J. Mouratoff, and J. E. Kaufman: Comparative treatment of the psychoneurotic reactive-type anxiety state with fluphenazine and chlordiazepoxide. J. New Drugs 3, 297–301 (1963).
Hollingshead, A. B.: Two-factor index of social position. Mimeographed report. New Haven, Conn. 1957.
Jenner, F. A., R. J. Kerry, and D. Parkin: A controlled trial of methaminodiazepoxide (chlordiazepoxide “librium”) in the treatment of anxiety in neurotic patients. J. ment. Sci. 10, 575–582 (1961).
Lipman, R. S., L. C. Park, and K. Rickels: Paradoxical influence of a therapeutic side effect interpretation. Arch. gen. Psychiat. 15, 462–474 (1966).
Rickels, K.: Some comments on non-drug factors in psychiatric drug therapy. Psychosomatics 6, 303–309 (1965a).
—, C. Baumm, E. Raab, W. Taylor, and E. Moore: A psychopharmacological evaluation of chlordiazepoxide, LA-1 and placebo, carried out with anxious, neurotic medical clinic patients. Med Tms N.Y. 98, 238–245 (1965b).
—, R. Boren, and H. M. Stuart: Controlled psychopharmacological research in general practice. J. New Drugs 4, 138–147 (1964a).
Rickels, K., R. B. Cattell, C. Weise, B. Gray, B. Yee, A. Mallin, and H. G. Aaronson: Controlled psychopharmacological research in private psychiatric practice. Psychopharmacologia (Berl.) 9, 288–306 (1966).
—, and A. MacAfee: Placebo responses in four neurotic patient populations. In: Neuropsychopharmacology, pp. 1087–1092, H. Brill, J. O. Cole, P. Deniker, H. Hippius, P. B. Bradley, eds. Amsterdam: Excerpta Medica Foundation 1967.
—, C. H. Ward, and L. Schut: Different populations, different drug responses. Amer. J. med. Sci. 247, 328–335 (1964b).
Stunkard, A. J.: Progress to uncertainty. Int. J. Psychiat. 2, 614–616 (1966).
Uhlenhuth, E. H., L. C. Park, R. S. Lipman, K. Rickels, S. Fisher, and J. Mock: Dosage deviation and drug effects in drug trials. J. nerv. ment. Dis. 141, 95–99 (1965).
— K. Rickels, S. Fisher, L. C. Park, R. S. Lipman, and J. Mock: Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia (Berl.) 9, 392–418 (1966).
Author information
Authors and Affiliations
Additional information
Research reported in this paper was supported by USPHS Grants MH-08957 and MH-08958 (Principal Investigator: Dr. Rickels). All medication was supplied by Dr. Michael Barry, White Laboratories, Inc. Permitil is the trade name for fluphenazine and Librium for chlordiazepoxide.
Rights and permissions
About this article
Cite this article
Rickels, K., Raab, E., Gordon, P.E. et al. Differential effects of chlordiazepoxide and fluphenazine in two anxious patient populations. Psychopharmacologia 12, 181–192 (1968). https://doi.org/10.1007/BF00403772
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403772